Genetic Technologies Ltd (NASDAQ:GENE)

1.08
Delayed Data
As of Jun 21
 +0.01 / +0.93%
Today’s Change
0.70
Today|||52-Week Range
2.05
-6.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-9.3M-7.3M-6.2M-6.3M
 
 
 
 
 
Depreciation310.7K193.4K283.9K280.3K
 
 
 
 
 
Total Other Cash Flow330.2K-1.2M289.4K594.1K
 
 
 
 
 
Funds From Operations-8.7M-8.3M-5.6M-5.5M
 
 
 
 
 
Funds From/For Other Operating Expenses1.4M-254.1K40.5K-324.8K
 
 
 
 
 
Net Cash Flow - Operating Activities-10.1M-8.1M-5.6M-5.1M
 
 
 
 
 
 
InvestingIncrease In Investments-104.8K0.000.000.00
 
 
Decrease In Investments530.1K0.000.000.00
 
 
Capital Expenditures-44.0K-160.4K-220.8K-177.1K
 
 
 
 
 
Fixed Asset Disposal0.001.8M5.2K39.7K
 
 
 
 
Net Assets From Acquisitions -149.2K0.000.000.00
 
 
Other Investing - Uses-18.8K0.000.000.00
 
 
Net Cash Flow Investing213.3K1.6M-215.6K-137.4K
 
 
 
 
 
 
FinancingShort Term Borrowings0.001.8M0.000.00
 
 
Long Term Borrowings5.1M--0.000.00
 
 
Long Term Debt Reduction0.00--0.000.00--
Net Proceeds Stock Sale5.8M17.3M-1.2K5.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00222.6K
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing10.9M19.0M-1.2K5.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-53.7K307.4K628.1K-230.5K
 
 
 
 
 
 
Net Change In Cash1.1M12.6M-5.8M86.2K